GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Formosa Pharmaceuticals Inc (TPE:6838) » Definitions » Capex-to-Revenue

Formosa Pharmaceuticals (TPE:6838) Capex-to-Revenue : 0.18 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Formosa Pharmaceuticals Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Formosa Pharmaceuticals's Capital Expenditure for the three months ended in Dec. 2024 was NT$-1.05 Mil. Its Revenue for the three months ended in Dec. 2024 was NT$5.90 Mil.

Hence, Formosa Pharmaceuticals's Capex-to-Revenue for the three months ended in Dec. 2024 was 0.18.


Formosa Pharmaceuticals Capex-to-Revenue Historical Data

The historical data trend for Formosa Pharmaceuticals's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Formosa Pharmaceuticals Capex-to-Revenue Chart

Formosa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Revenue
Get a 7-Day Free Trial - 0.53 - 0.07 0.06

Formosa Pharmaceuticals Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 1.05 0.25 0.18

Competitive Comparison of Formosa Pharmaceuticals's Capex-to-Revenue

For the Biotechnology subindustry, Formosa Pharmaceuticals's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Pharmaceuticals's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formosa Pharmaceuticals's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Formosa Pharmaceuticals's Capex-to-Revenue falls into.



Formosa Pharmaceuticals Capex-to-Revenue Calculation

Formosa Pharmaceuticals's Capex-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-8.248) / 143.356
=0.06

Formosa Pharmaceuticals's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1.051) / 5.895
=0.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Formosa Pharmaceuticals  (TPE:6838) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Formosa Pharmaceuticals Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Formosa Pharmaceuticals's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Formosa Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 57, Fuxing North Road, 8th Floor 6, Songshan District, Taipei, TWN, 105
Formosa Pharmaceuticals Inc. is a late-preclinical and early-clinical-stage biopharmaceutical company with a focus on the indications of ophthalmology, oncology, and anti-infectives.

Formosa Pharmaceuticals Headlines

No Headlines